2-FDCK: DEA Move to Emergency-Schedule Ketamine Analog Draws Fire – Filter Mag
Today Filter Magazine published an article discussing the DEA’s announcement to place 2-fluorodeschloroketamine (2-FDCK)—a structural analog of the anesthetic and antidepressant ketamine—into Schedule I of the Controlled Substances Act, effectively banning it. Kat Murti, SSDP’s Executive Director, was quoted in the article.
Kat Murti, executive director of Students for Sensible Drug Policy (SSDP), the nation’s largest youth-led drug policy reform organization, shares these concerns.
“The DEA’s move to emergency-schedule 2-FDCK as a Schedule I substance is drug policy by panic, not evidence, and we will pay for it in blood,” she told Filter. “Emergency scheduling sidesteps scientific review and public-health input, replacing them with blunt enforcement tools that have repeatedly proven deadly.”“We’ve seen this pattern over and over again: Rushed bans create chaos, not safety,” Murti continued. “Placing ketamine analogs into Schedule I will not eliminate use or make communities safer. It will push people toward increasingly unregulated and unpredictable markets, increase the risk of adulteration and overdose, and expose people—especially young people—to arrest, incarceration, and lifelong consequences.”
